Cannabidiol and Cannabis Concentrate Users: A Randomized, Placebo Controlled Study
Primary Objective
The purpose of this research study is to learn more about how cannabidiol (CBD) may affect cannabis use, effects, and craving.
Description
Study participation will include 4 visits over about 5 weeks, with an on-campus screening visit and three home-based visits in our mobile pharmacology lab, a specially equipped van. Participation will involve taking cannabidiol (CBD) or a placebo.
Details
Age
Adult
Eligibility
Inclusion Criteria:
- Age 25-60
- Regular user of cannabis concentrates
- Not currently seeking to cut down or stop cannabis useNot everyone will qualify to be in the study. Other inclusion and exclusion criteria will be evaluated by the study team.
Locations
Outpatient CTRC
University of Colorado Hospital
Principal Investigator
Joseph Schacht
Study ID
Protocol Number: 23-0953
More information available at ClinicalTrials.gov: NCT06575751
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers